Related Experiment Video
Updated: Jun 27, 2026

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth
Published on: September 22, 2021
Apoptotic Signaling Across Breast Cancer Subtypes and Cryoablation-Induced Tissue Injury
Agata Panfil1, Kacper Boroń2,3,4,5, Tomasz Sirek1,2,6
1Collegium Medicum, WSB University, 41-300 Dąbrowa Górnicza, Poland.
Abstract:
Apoptosis maintains tissue homeostasis, and its dysregulation is closely associated with breast cancer progression and therapeutic resistance. We performed an integrative analysis of apoptosis-related signaling in breast cancer tissues across five molecular subtypes and compared these patterns with systemic apoptotic responses following cryoablation of benign fibroadenomas. Gene expression profiling was conducted using mRNA microarrays and validated by qRT-PCR and ELISA. Apoptosis pathway activity was assessed with the MSigDB HALLMARK_APOPTOSIS gene set, including intrinsic and extrinsic pathway scoring and an apoptotic balance index (ABI). MicroRNA profiling combined with in silico analyses identified potential miRNA-mRNA interactions. A progressive shift toward reduced pro-apoptotic and enhanced stress-adaptive signaling was observed with increasing tumor aggressiveness, most pronounced in triple-negative and non-luminal HER2-positive cancers. This pattern included reduced intrinsic pathway activity, decreased ABI, downregulation of pro-apoptotic genes (BIK, BMF, TXNIP), and upregulation of stress-associated or cytoprotective genes (HSPB1, PPT1). Several expression patterns were accompanied by overexpression of miRNAs (miR-582-5p, miR-421, miR-106b-5p, miR-20a-5p, miR-20b-5p, miR-93-5p) predicted to target apoptosis-related genes. In contrast, fibroadenoma cryoablation was associated with transient systemic modulation of apoptosis-related genes and proteins followed by gradual normalization. These findings highlight differences between apoptosis-related dysregulation in malignant tissue and regulated systemic responses following benign tissue injury, supporting pathway-level interpretation and identifying candidate molecular networks warranting further mechanistic and translational investigation.
Insights
Breast cancer progression shows altered apoptosis signaling, with reduced pro-apoptotic activity and increased stress adaptation in aggressive tumors. This contrasts with transient systemic responses observed after benign fibroadenoma cryoablation.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Apoptosis is crucial for tissue homeostasis; its dysregulation drives breast cancer progression and therapeutic resistance.
- Understanding apoptosis signaling across breast cancer subtypes is vital for targeted therapies.
Purpose of the Study:
- To investigate apoptosis-related signaling patterns in breast cancer molecular subtypes.
- To compare malignant apoptosis dysregulation with systemic responses to benign tissue injury (cryoablation).
Main Methods:
- Integrative analysis of gene expression (mRNA microarrays, qRT-PCR) and protein levels (ELISA) in breast cancer tissues.
- Assessment of apoptosis pathway activity using MSigDB HALLMARK_APOPTOSIS gene set, intrinsic/extrinsic pathway scoring, and apoptotic balance index (ABI).
- MicroRNA profiling and in silico analyses to identify miRNA-mRNA interactions.
Main Results:
- Aggressive breast cancers exhibit reduced pro-apoptotic signaling and increased stress-adaptive responses, particularly in triple-negative and HER2-positive subtypes.
- Key findings include decreased intrinsic pathway activity, lower ABI, downregulation of pro-apoptotic genes (BIK, BMF, TXNIP), and upregulation of stress genes (HSPB1, PPT1).
- Overexpression of specific miRNAs (e.g., miR-582-5p, miR-421) correlated with apoptosis-related gene expression changes.
Conclusions:
- Breast cancer malignancy is characterized by distinct apoptosis pathway dysregulation compared to the transient systemic responses seen after benign fibroadenoma cryoablation.
- Findings identify potential molecular networks (miRNA-mRNA interactions) involved in breast cancer progression and therapeutic resistance.
- Pathway-level interpretation highlights differences between malignant dysregulation and regulated physiological responses.
More Related Videos
11:21Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway